In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. The number of cases in the UK increased significantly at the end of 2021. On January 13, 2023, the number of confirmed cases in the UK amounted to 24,243,393. COVID deaths among highest in Europe There were 202,157 confirmed coronavirus deaths in the UK as of January 13, 2023. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Current infection rate in Europe The current infection rate in the UK was 50 cases per 100,000 population in the last seven days as of January 16. San Marino had the highest seven day rate of infections in Europe at 336.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
The number of deaths registered in England and Wales due to and involving coronavirus (COVID-19). Breakdowns include age, sex, region, local authority, Middle-layer Super Output Area (MSOA), indices of deprivation and place of death. Includes age-specific and age-standardised mortality rates.
Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.
The difficulties of death figures
This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.
Where are these numbers coming from?
The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United Kingdom recorded 24603076 Coronavirus Cases since the epidemic began, according to the World Health Organization (WHO). In addition, United Kingdom reported 225324 Coronavirus Deaths. This dataset includes a chart with historical data for the United Kingdom Coronavirus Cases.
As of June 13, 2023, there have been almost 768 million cases of coronavirus (COVID-19) worldwide. The disease has impacted almost every country and territory in the world, with the United States confirming around 16 percent of all global cases.
COVID-19: An unprecedented crisis Health systems around the world were initially overwhelmed by the number of coronavirus cases, and even the richest and most prepared countries struggled. In the most vulnerable countries, millions of people lacked access to critical life-saving supplies, such as test kits, face masks, and respirators. However, several vaccines have been approved for use, and more than 13 billion vaccine doses had already been administered worldwide as of March 2023.
The coronavirus in the United Kingdom Over 202 thousand people have died from COVID-19 in the UK, which is the highest number in Europe. The tireless work of the National Health Service (NHS) has been applauded, but the country’s response to the crisis has drawn criticism. The UK was slow to start widespread testing, and the launch of a COVID-19 contact tracing app was delayed by months. However, the UK’s rapid vaccine rollout has been a success story, and around 53.7 million people had received at least one vaccine dose as of July 13, 2022.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Headline estimates for England, Wales, Northern Ireland and Scotland.
Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
Within the current response of a pandemic caused by the SARS-CoV-2 coronavirus, which in turn causes the disease, called COVID-19. It is necessary to join forces to minimize the effects of this disease.
Therefore, the intention of this dataset is to save data scientists time:
This dataset is not intended to be static, so suggestions for expanding it are welcome. If someone considers it important to add information, please let me know.
The data contained in this dataset comes mainly from the following sources:
Source: Center for Systems Science and Engineering (CSSE) at Johns Hopkins University https://github.com/CSSEGISandData/COVID-19 Provided by Johns Hopkins University Center for Systems Science and Engineering (JHU CSSE): https://systems.jhu.edu/
Source: OXFORD COVID-19 GOVERNMENT RESPONSE TRACKER https://www.bsg.ox.ac.uk/research/research-projects/oxford-covid-19-government-response-tracker Hale, Thomas and Samuel Webster (2020). Oxford COVID-19 Government Response Tracker. Data use policy: Creative Commons Attribution CC BY standard.
The original data is updated daily.
The features it includes are:
Country Name
Country Code ISO 3166 Alpha 3
Date
Incidence data:
Daily increments:
Empirical Contagion Rate - ECR
https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F3508582%2F3e90ecbcdf76dfbbee54a21800f5e0d6%2FECR.jpg?generation=1586861653126435&alt=media" alt="">
GOVERNMENT RESPONSE TRACKER - GRTStringencyIndex
OXFORD COVID-19 GOVERNMENT RESPONSE TRACKER - Stringency Index
Indices from Start Contagion
Percentages over the country's population:
The method of obtaining the data and its transformations can be seen in the notebook:
Notebook COVID-19 Data by country with Government Response
Photo by Markus Spiske on Unsplash
As of May 2, 2023, there were roughly 687 million global cases of COVID-19. Around 660 million people had recovered from the disease, while there had been almost 6.87 million deaths. The United States, India, and Brazil have been among the countries hardest hit by the pandemic.
The various types of human coronavirus The SARS-CoV-2 virus is the seventh known coronavirus to infect humans. Its emergence makes it the third in recent years to cause widespread infectious disease following the viruses responsible for SARS and MERS. A continual problem is that viruses naturally mutate as they attempt to survive. Notable new variants of SARS-CoV-2 were first identified in the UK, South Africa, and Brazil. Variants are of particular interest because they are associated with increased transmission.
Vaccination campaigns Common human coronaviruses typically cause mild symptoms such as a cough or a cold, but the novel coronavirus SARS-CoV-2 has led to more severe respiratory illnesses and deaths worldwide. Several COVID-19 vaccines have now been approved and are being used around the world.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
This open data publication has moved to COVID-19 Statistical Data in Scotland (from 02/11/2022) Novel coronavirus (COVID-19) is a new strain of coronavirus first identified in Wuhan, China. Clinical presentation may range from mild-to-moderate illness to pneumonia or severe acute respiratory infection. This dataset provides information on demographic characteristics (age, sex, deprivation) of confirmed novel coronavirus (COVID-19) cases, as well as trend data regarding the wider impact of the virus on the healthcare system. Data includes information on primary care out of hours consultations, respiratory calls made to NHS24, contact with COVID-19 Hubs and Assessment Centres, incidents received by Scottish Ambulance Services (SAS), as well as COVID-19 related hospital admissions and admissions to ICU (Intensive Care Unit). Further data on the wider impact of the COVID-19 response, focusing on hospital admissions, unscheduled care and volume of calls to NHS24, is available on the COVID-19 Wider Impact Dashboard. There is a large amount of data being regularly published regarding COVID-19 (for example, Coronavirus in Scotland - Scottish Government and Deaths involving coronavirus in Scotland - National Records of Scotland. Additional data sources relating to this topic area are provided in the Links section of the Metadata below. Information on COVID-19, including stay at home advice for people who are self-isolating and their households, can be found on NHS Inform. All publications and supporting material to this topic area can be found in the weekly COVID-19 Statistical Report. The date of the next release can be found on our list of forthcoming publications. Data visualisation is available to view in the interactive dashboard accompanying the COVID-19 Statistical Report. Please note information on COVID-19 in children and young people of educational age, education staff and educational settings is presented in a new COVID-19 Education Surveillance dataset going forward.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Findings from the Coronavirus (COVID-19) Infection Survey for England.
CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
Due to changes in the collection and availability of data on COVID-19, this dataset is no longer updated. Latest information about COVID-19 is available via the UKHSA data dashboard. The UK government publish daily data, updated weekly, on COVID-19 cases, vaccinations, hospital admissions and deaths. This note provides a summary of the key data for London from this release. Data are published through the UK Coronavirus Dashboard, last updated on 23 March 2023. This update contains: Data on the number of cases identified daily through Pillar 1 and Pillar 2 testing at the national, regional and local authority level Data on the number of people who have been vaccinated against COVID-19 Data on the number of COVID-19 patients in Hospital Data on the number of people who have died within 28 days of a COVID-19 diagnosis Data for London and London boroughs and data disaggregated by age group Data on weekly deaths related to COVID-19, published by the Office for National Statistics and NHS, is also available. Key Points On 23 March 2023 the daily number of people tested positive for COVID-19 in London was reported as 2,775 On 23 March 2023 it was newly reported that 94 people in London died within 28 days of a positive COVID-19 test The total number of COVID-19 cases identified in London to date is 3,146,752 comprising 15.2 percent of the England total of 20,714,868 cases In the most recent week of complete data (12 March 2023 - 18 March 2023) 2,951 new cases were identified in London, a rate of 33 cases per 100,000 population. This compares with 2,883 cases and a rate of 32 for the previous week In England as a whole, 29,426 new cases were identified in the most recent week of data, a rate of 52 cases per 100,000 population. This compares with 26,368 cases and a rate of 47 for the previous week Up to and including 22 March 2023 6,452,895 people in London had received the first dose of a COVID-19 vaccine and 6,068,578 had received two doses Up to and including 22 March 2023 4,435,586 people in London had received either a third vaccine dose or a booster dose On 22 March 2023 there were 1,370 COVID-19 patients in London hospitals. This compares with 1,426 patients on 15 March 2023. On 22 March 2023 there were 70 COVID-19 patients in mechanical ventilation beds in London hospitals. This compares with 72 patients on 15 March 2023. Update: From 1st July updates are weekly From Friday 1 July 2022, this page will be updated weekly rather than daily. This change results from a change to the UK government COVID-19 Dashboard which will move to weekly reporting. Weekly updates will be published every Thursday. Daily data up to the most recent available will continue to be added in each weekly update. Data summary 리소스 CSV phe_vaccines_age_london_boroughs.csv CSV 다운로드 phe_vaccines_age_london_boroughs.csv CSV phe_healthcare_admissions_age.csv CSV 다운로드
This dataset contains daily data trackers for the COVID-19 pandemic, aggregated by month and starting 18.3.20. The first release of COVID-19 data on this platform was on 1.6.20. Updates have been provided on a quarterly basis throughout 2023/24. No updates are currently scheduled for 2024/25 as case rates remain low. The data is accurate as at 8.00 a.m. on 8.4.24. Some narrative for the data covering the latest period is provided here below: Diagnosed cases / episodes • As at 3.4.24 CYC residents have had a total 75,556 covid episodes since the start of the pandemic, a rate of 37,465 per 100,000 of population (using 2021 Mid-Year Population estimates). The cumulative rate in York is similar to the national (37,305) and regional (37,059) averages. • The latest rate of new Covid cases per 100,000 of population for the period 28.3.24 to 3.4.24 in York was 1.49 (3 cases). The national and regional averages at this date were 1.67 and 2.19 respectively (using data published on Gov.uk on 5.4.24).
COVID-19 rate of death, or the known deaths divided by confirmed cases, was over ten percent in Yemen, the only country that has 1,000 or more cases. This according to a calculation that combines coronavirus stats on both deaths and registered cases for 221 different countries. Note that death rates are not the same as the chance of dying from an infection or the number of deaths based on an at-risk population. By April 26, 2022, the virus had infected over 510.2 million people worldwide, and led to a loss of 6.2 million. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.
Where are these numbers coming from?
The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. Note that Statista aims to also provide domestic source material for a more complete picture, and not to just look at one particular source. Examples are these statistics on the confirmed coronavirus cases in Russia or the COVID-19 cases in Italy, both of which are from domestic sources. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.
A word on the flaws of numbers like this
People are right to ask whether these numbers are at all representative or not for several reasons. First, countries worldwide decide differently on who gets tested for the virus, meaning that comparing case numbers or death rates could to some extent be misleading. Germany, for example, started testing relatively early once the country’s first case was confirmed in Bavaria in January 2020, whereas Italy tests for the coronavirus postmortem. Second, not all people go to see (or can see, due to testing capacity) a doctor when they have mild symptoms. Countries like Norway and the Netherlands, for example, recommend people with non-severe symptoms to just stay at home. This means not all cases are known all the time, which could significantly alter the death rate as it is presented here. Third and finally, numbers like this change very frequently depending on how the pandemic spreads or the national healthcare capacity. It is therefore recommended to look at other (freely accessible) content that dives more into specifics, such as the coronavirus testing capacity in India or the number of hospital beds in the UK. Only with additional pieces of information can you get the full picture, something that this statistic in its current state simply cannot provide.
https://www.ons.gov.uk/aboutus/whatwedo/statistics/requestingstatistics/approvedresearcherschemehttps://www.ons.gov.uk/aboutus/whatwedo/statistics/requestingstatistics/approvedresearcherscheme
The purpose of this dataset is to understand the prevalence of the coronavirus in the UK population, using longitudinal data and including not only cross-sectional data but the inclusion of an antibody test for a sub-sample of people. Demographic information is also included allowing for analyse by different variables to identify patterns and trends.
Participants have three options open to them; can have just have one visit, can have a visit every week for a month or, can have a visit every week for a month and then continue to have visits every month for one year in total from when you joined the study. This is entirely voluntary.
At each visit a field worker conducts a questionnaire, and supervises swab tests. A proportion of visits also include a blood sample being taken. The swab and blood samples are tested at laboratories.
The overall purpose of this study is to understand how many people across the UK have or may already have had the coronavirus. This will help the government manage the pandemic moving forwards.
The COVID-19 Community Infection Survey includes information on: • how many people across England and Wales (extending to Scotland and Northern Ireland) test positive for COVID-19 at a given point in time, regardless of whether they report experiencing symptoms • the average number of new infections per week over the course of the study • the number of people who test positive for antibodies, to indicate how many people are ever likely to have had the virus • key demographic information (sex, age, occupation)
The COVID-19 Health Inequalities Monitoring in England (CHIME) tool brings together data relating to the direct impacts of coronavirus (COVID-19) on factors such as mortality rates, hospital admissions, confirmed cases and vaccinations.
By presenting inequality breakdowns - including by age, sex, ethnic group, level of deprivation and region - the tool provides a single point of access to:
In the March 2023 update, data has been updated for deaths, hospital admissions and vaccinations. Data on inequalities in vaccination uptake within upper tier local authorities has been added to the tool for the first time. This replaces data for lower tier local authorities, published in December 2022, allowing the reporting of a wider range of inequality breakdowns within these areas.
Updates to the CHIME tool are paused pending the results of a review of the content and presentation of data within the tool. The tool has not been updated since the 16 March 2023.
Please send any questions or comments to PHA-OHID@dhsc.gov.uk
These are the key findings from the second of three rounds of the DCMS Coronavirus Business Survey. These surveys are being conducted to help DCMS understand how our sectors are responding to the ongoing Coronavirus pandemic. The data collected is not longitudinal as responses are voluntary, meaning that businesses have no obligation to complete multiple rounds of the survey and businesses that did not submit a response to one round are not excluded from response collection in following rounds.
The indicators and analysis presented in this bulletin are based on responses from the voluntary business survey, which captures organisations responses on how their turnover, costs, workforce and resilience have been affected by the coronavirus (COVID-19) outbreak. The results presented in this release are based on 3,870 completed responses collected between 17 August and 8 September 2020.
This is the first time we have published these results as Official Statistics. An earlier round of the business survey can be found on gov.uk.
We have designated these as Experimental Statistics, which are newly developed or innovative statistics. These are published so that users and stakeholders can be involved in the assessment of their suitability and quality at an early stage.
We expect to publish a third round of the survey before the end of the financial year. To inform that release, we would welcome any user feedback on the presentation of these results to evidence@dcms.gov.uk by the end of November 2020.
The survey was run simultaneously through DCMS stakeholder engagement channels and via a YouGov panel.
The two sets of results have been merged to create one final dataset.
Invitations to submit a response to the survey were circulated to businesses in relevant sectors through DCMS stakeholder engagement channels, prompting 2,579 responses.
YouGov’s business omnibus panel elicited a further 1,288 responses. YouGov’s respondents are part of their panel of over one million adults in the UK. A series of pre-screened information on these panellists allows YouGov to target senior decision-makers of organisations in DCMS sectors.
One purpose of the survey is to highlight the characteristics of organisations in DCMS sectors whose viability is under threat in order to shape further government support. The timeliness of these results is essential, and there are some limitations, arising from the need for this timely information:
This release is published in accordance with the Code of Practice for Statistics, as produced by the UK Statistics Authority. The Authority has the overall objective of promoting and safeguarding the production and publication of official statistics that serve the public good. It monitors and reports on all official statistics, and promotes good practice in this area.
The responsible statistician for this release is Alex Bjorkegren. For further details about the estimates, or to be added to a distribution list for future updates, please email us at evidence@dcms.gov.uk.
The document above contains a list of ministers and officials who have received privileged early access to this release. In line with best practice, the list has been kept to a minimum and those given access for briefing purposes had a maximum of 24 hours.
These reports summarise the surveillance of influenza, COVID-19 and other seasonal respiratory illnesses.
Weekly findings from community, primary care, secondary care and mortality surveillance systems are included in the reports.
This page includes reports published from 14 July 2022 to 6 July 2023.
Previous reports on influenza surveillance are also available for:
View previous COVID-19 surveillance reports.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Experimental estimates of the prevalence and duration of long COVID symptoms, and rates of adverse events for hospitalised coronavirus (COVID-19) patients compared with those for matched control patients.
The purpose of this dataset is to understand the prevalence of COVID-19 in the UK population, including swab results, antibody tests and demographic information.
http://reference.data.gov.uk/id/open-government-licencehttp://reference.data.gov.uk/id/open-government-licence
Estimates of the risk of hospital admission for coronavirus (COVID-19) and death involving COVID-19 by vaccination status, overall and by age group, using anonymised linked data from Census 2021. Experimental Statistics.
Outcome definitions
For this analysis, we define a death as involving COVID-19 if either of the ICD-10 codes U07.1 (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified) is mentioned on the death certificate. Information on cause of death coding is available in the User Guide to Mortality Statistics. We use date of occurrance rather than date of registration to give the date of the death.
We define COVID-109 hospitalisation as an inpatient episode in Hospital Episode Statistics where the primary diagnosis was COVID-19, identified by the ICD-19 codes (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified). Where an individual had experienced more than one COVID-19 hospitalisation, the earliest that occurred within the study period was used. We define the date of COVID-19 hospitalisation as the start of the hospital episode.
ICD-10 code
U07.1 :
COVID-19, virus identified
U07.2:
COVID-19, virus not identified
Vaccination status is defined by the dose and the time since the last dose received
Unvaccinated:
no vaccination to less than 21 days post first dose
First dose 21 days to 3 months:
more than or equal to 21 days post second dose to earliest of less than 91 days post first dose or less than 21 days post second dose
First dose 3+ months:
more than or equal to 91 days post first dose to less than 21 days post second dose
Second dose 21 days to 3 months:
more than or equal to 21 days post second dose to earliest of less than 91 days post second dose or less than 21 days post third dose
Second dose 3-6 months:
more than or equal to 91 days post second dose to earliest of less than 182 days post second dose or less than 21 days post third dose
Second dose 6+ months:
more than or equal to 182 days post second dose to less than 21 days post third dose
Third dose 21 days to 3 months:
more than or equal to 21 days post third dose to less than 91 days post third dose
Third dose 3+ months:
more than or equal to 91 days post third dose
Model adjustments
Three sets of model adjustments were used
Age adjusted:
age (as a natural spline)
Age, socio-demographics adjusted:
age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status)
Fully adjusted:
age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status), plus health-related characteristics (disability, self-reported health, care home residency, number of QCovid comorbidities (grouped), BMI category, frailty flag and hospitalisation within the last 21 days.
Age
Age in years is defined on the Census day 2021 (21 March 2021). Age is included in the model as a natural spline with boundary knots at the 10th and 90th centiles and internal knots at the 25th, 50th and 75th centiles. The positions of the knots are calculated separately for the overall model and for each age group for the stratified model.
In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. The number of cases in the UK increased significantly at the end of 2021. On January 13, 2023, the number of confirmed cases in the UK amounted to 24,243,393. COVID deaths among highest in Europe There were 202,157 confirmed coronavirus deaths in the UK as of January 13, 2023. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Current infection rate in Europe The current infection rate in the UK was 50 cases per 100,000 population in the last seven days as of January 16. San Marino had the highest seven day rate of infections in Europe at 336.